Abstract
The aim of this study was to investigate the regulation of interleukin (IL)-12 and IL-23 expression in the autoimmune disease, systemic lupus erythematosus (SLE). mRNA from healthy subjects and SLE patients were prepared from peripheral blood mononuclear cells (PBMC) and quantitative real-time polymerase chain reaction was performed to quantify IL-23 specific subunit P19, IL-12 specific subunit P35, and their common subunit P40. IL-12 specific subunit P35 mRNA expression in untreated and treated SLE patients was significantly lower than healthy controls (P = 0.015 and 0.000, respectively). Compared with untreated SLE patients, treatment of SLE patients with corticosteroids or corticosteroids plus another immunosuppressor significantly suppressed P40 and P19 expression (P = 0.002 and 0.015, respectively). The mRNA levels of p19, p40, and p35 in active SLE patients (SLEDAT > 10) were significantly higher compared with those in the inactive SLE patients (SLEDAI ≤ 10) (P = 0.000, 0.000, and 0.017, respectively). These results suggest that deficiency of IL-12 and possibly upregulation of IL-23 may contribute to SLE pathogenesis and both cytokines may be therapeutic targets in SLE.
Similar content being viewed by others
References
JP Leonard KE Waldburger SJ Goldman (1996) ArticleTitleRegulation of experimental autoimmune encephalomyelitis by interleukin-12 Ann NY Acad Sci 795 216–26 Occurrence Handle8958933 Occurrence Handle10.1111/j.1749-6632.1996.tb52671.x Occurrence Handle1:CAS:528:DyaK2sXhtV2gtr8%3D
CS Constantinescu M Wysocka B Hilliard ES Ventura E Lavi G Trinchieri et al. (1998) ArticleTitleAntibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis J Immunol 161 5097–104 Occurrence Handle9794448 Occurrence Handle1:CAS:528:DyaK1cXntVWlurg%3D
BM Segal BK Dwyer EM Shevach (1998) ArticleTitleAn interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease J Exp Med 187 537–46 Occurrence Handle9463404 Occurrence Handle10.1084/jem.187.4.537 Occurrence Handle1:CAS:528:DyaK1cXhtFCqtLs%3D
DJ Cua J Sherlock Y Chen CA Murphy B Joyce B Seymour et al. (2003) ArticleTitleInterleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain Nature 421 744–8 Occurrence Handle12610626 Occurrence Handle10.1038/nature01355 Occurrence Handle1:CAS:528:DC%2BD3sXhsV2rsbs%3D
CA Murphy CL Langrish Yi Chen W Blumenschein T McClanahan RA Kastelein et al. (2003) ArticleTitleDivergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation J Exp Med 198 1951–7 Occurrence Handle14662908 Occurrence Handle10.1084/jem.20030896 Occurrence Handle1:CAS:528:DC%2BD3sXpvFakur4%3D
MC Hochberg (1997) ArticleTitleUpdating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter Arthritis Rheum 40 1725 Occurrence Handle9324032 Occurrence Handle10.1002/art.1780400928 Occurrence Handle1:STN:280:ByiH28vitFU%3D
DD Gladman D Ibanez MB Urowitz (2002) ArticleTitleSystemic lupus erythematosus disease activity index 2000 J Rheumatol 29 288–91 Occurrence Handle11838846
M Kobayashi L Fitz M Ryan RM Hewick SC Clark S Chan et al. (1989) ArticleTitleIdentification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes J Exp Med 170 IssueID3 827–45 Occurrence Handle2504877 Occurrence Handle10.1084/jem.170.3.827 Occurrence Handle1:CAS:528:DyaL1MXlvFarsr8%3D
G Trinchieri M Wysocka A D'Andrea M Rengaraju M Aste-Amezaga M Kubin et al. (1992) ArticleTitleNatural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation Prog Growth Factor Res 4 IssueID4 355–68 Occurrence Handle1364096 Occurrence Handle10.1016/0955-2235(92)90016-B Occurrence Handle1:CAS:528:DyaK2cXhtlWmsrw%3D
B Gran GX Zhang S Yu Jf Li XH Chen ES Ventura et al. (2002) ArticleTitleIL-12p35-Deficient Mice Are Susceptible to Experimental Autoimmune Encephalomyelitis: Evidence for Redundancy in the IL-12 System in the Induction of Central Nervous System Autoimmune Demyelination J Immunol 169 7104–10 Occurrence Handle12471147 Occurrence Handle1:CAS:528:DC%2BD38XpsFGjtr8%3D
B Oppmann R Lesley B Blom JC Timans YM Xu B Hunte et al. (2000) ArticleTitleNovel p19 Protein Engages IL-12p40 to Form a Cytokine, IL-23, with Biological Activities Similar as Well as Distinct from IL-12 Immunity 13 715–25 Occurrence Handle11114383 Occurrence Handle10.1016/S1074-7613(00)00070-4 Occurrence Handle1:CAS:528:DC%2BD3cXovV2ht7c%3D
VE Lee WL Trepicchio JL Oestreicher D Pittman F Wang F Chamian et al. (2004) ArticleTitleIncreased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis J Exp Med 199 IssueID1 125–30 Occurrence Handle14707118 Occurrence Handle10.1084/jem.20030451 Occurrence Handle1:CAS:528:DC%2BD2cXjvFWktw%3D%3D
M Funauchi S Ikoma H Enomoto A Horiuchi (1998) ArticleTitleDecreased Th1-like and increased Th2-like cells in systemic lupus erythematosus Scand J Rheumatol 27 219–24 Occurrence Handle9645418 Occurrence Handle10.1080/030097498440859 Occurrence Handle1:STN:280:DyaK1czgslehtw%3D%3D
MR Amel-Kashipaz ML Huggins P Lanyon A Robins I Todd RJ Powell (2001) ArticleTitleQuantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(−) and CD8(+) T cells in systemic lupus erythematosus J Autoimmun 17 IssueID2 155–63 Occurrence Handle11591124 Occurrence Handle10.1006/jaut.2001.0525 Occurrence Handle1:STN:280:DC%2BD3Mrktlegtg%3D%3D
AC Allison EM Eugui (2005 Oct 15) ArticleTitleMechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection Transplantation 80 IssueID2 Suppl S181–90 Occurrence Handle10.1097/01.tp.0000186390.10150.66 Occurrence Handle1:CAS:528:DC%2BD2MXhtFGhsL7M
SI Kuzmanova (2005) ArticleTitleThe macrophage activation syndrome: a new entity, a potentially fatal complication of rheumatic disorders Folia Med (Plovdiv) 47 IssueID1 21–5
Y Tokano S Morimoto H Kaneko H Amano K Nozawa Y Takasaki et al. (1999) ArticleTitleLevels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)–relation to Th1- and Th2-derived cytokines C lin Exp Immunol 116 IssueID1 169–73 Occurrence Handle10.1046/j.1365-2249.1999.00862.x Occurrence Handle1:CAS:528:DyaK1MXis1Cntrk%3D
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Huang, X., Hua, J., Shen, N. et al. Dysregulated expression of interleukin-23 and interleukin-12 subunits in systemic lupus erythematosus patients. Mod Rheumatol 17, 220–223 (2007). https://doi.org/10.1007/s10165-007-0568-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10165-007-0568-9